30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
Australia

PARADIGM BIOPHARMACEUTICALS LIMITED.. (PAR)

Track

Top insiders
Trades
Helen Fisher
1 purchase — total 439 AUD
Buy 30 Nov 2023
Value A$205,244.87 | Price 107.63 | Shares 62,171
Buy 30 Nov 2023
Value A$3,064,332.50 | Price 10.50 | Shares 85,272
Buy 18 May 2023
Value A$10,020.00 | Price 0.98 | Shares 10,204
Buy 12 May 2023
Value A$76,001.00 | Price 1.03 | Shares 73,851
Buy 19 Dec 2022
Value A$61,521.00 | Price 1.29 | Shares 47,720
Buy 14 Sep 2022
Value A$303,999.00 | Price 1.30 | Shares 233,845
Buy 25 Jan 2022
Value A$708,750.00 | Price 1.89 | Shares 375,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-12-01 2023-11-30 B Purchase Helen Fisher Director
62,171
107.63
A$205,245 		62,171 107.63 A$205,245
2023-11-30 2023-11-30 B Purchase Paul Rennie Director
85,272
10.50
A$3,064,333 		85,272 10.50 A$3,064,333
2023-05-22 2023-05-18 B Purchase Helen Fisher Director
4,575
451.96
A$919,777 		4,575 451.96 A$919,777
2023-05-17 2023-05-12 B Purchase Paul Rennie Director
73,851
1.03
A$76,001 		73,851 1.03 A$76,001
2022-12-22 2022-12-19 B Purchase Paul Rennie Director
47,720
1.29
A$61,521 		47,720 1.29 A$61,521
2022-09-19 2022-09-14 B Purchase Paul Rennie Director
233,845
1.30
A$303,999 		233,845 1.30 A$303,999
2022-02-01 2022-01-25 B Purchase Donna Skerrett Director
375,000
1.89
A$708,750 		375,000 1.89 A$708,750
Explore more

More insider trading research around PARADIGM BIOPHARMACEUTICALS LIMITED..

More insider trades in Australia
Insider trading in Asia-Pacific